Amgen Files ITC Complaint Over Roche Anemia Drug
In a move to block pharmaceutical company Roche Holding AG's experimental anemia drug from entering the United States, biotechnology company Amgen Inc. filed a complaint Tuesday with the U.S. International Trade...To view the full article, register now.
Already a subscriber? Click here to view full article